Skip to content

Medicare Advantage Overbilling: A Call for Reform

The Medicare Advantage (MA) industry, once hailed as a cost-effective alternative to traditional Medicare, has recently been scrutinized for rampant overbilling and unethical practices. Behind the scenes, MA providers are funneling millions of dollars into lobbying efforts to protect their lucrative arrangements, effectively buying political influence to keep their profits intact. This raises serious questions about the integrity of a system designed to serve seniors but instead appears to serve the bottom lines of private insurers.

The Overbilling Problem

The federal government pays each enrollee a fixed amount for Medicare Advantage plans offered by private insurers. The idea is that MA plans can manage care more efficiently and provide benefits at a lower cost compared to traditional Medicare. However, these plans have been systematically overbilling the government by exaggerating the health risks of their enrollees, allowing them to collect higher payments from Medicare.

A 2023 Department of Health and Human Services (HHS) report estimated that improper payments to Medicare Advantage plans totaled more than $16 billion in 2022 alone. Much of this is due to “upcoding,” where insurers classify enrollees as sicker than they are, inflating the reimbursement they receive. As a result, Medicare Advantage is draining public resources and driving up healthcare costs.

How Lobbying Dollars Keep the Gravy Train Going

Faced with growing scrutiny over these practices, the MA industry has responded not by cleaning up its act but by aggressively lobbying to maintain its profitable status quo. In 2023, Medicare Advantage insurers spent over $70 million on lobbying efforts, aiming to influence Congress and federal regulators.

These lobbying efforts are focused on two main objectives: preventing regulatory crackdowns on overbilling and securing favorable policy changes. Medicare Advantage’s powerful lobbyists have targeted key lawmakers, ensuring that legislation to curb overbilling is either watered down or never sees the light of day.

Buying Political Influence

The lobbying efforts of the Medicare Advantage industry don’t just influence policy—they actively shape it. In the past few years, many politicians have received significant campaign contributions from private insurers, which, in turn, has made these elected officials hesitant to push for reforms that could curb overbilling practices.

These relationships have also led to policy decisions that favor the industry. For instance, when there was a push to reduce the amount of taxpayer money funneled into Medicare Advantage plans through risk adjustments, lobbyists succeeded in maintaining much of the existing payment structure. As a result, insurers have continued to reap massive profits while taxpayers foot the bill for the overcharges.

The Impact on Seniors and Taxpayers

While private insurers benefit from this system, seniors and taxpayers bear the brunt of the costs. The overbilling of Medicare Advantage plans drains Medicare’s trust fund, threatening the program’s sustainability for future generations. Moreover, these practices can also harm patients. Many Medicare Advantage enrollees are funneled into narrow networks of healthcare providers, and insurers sometimes deny or delay coverage for necessary treatments to cut costs and boost profits.

This problem has created a situation in which the very program designed to help seniors could, in the long run, reduce the quality of care and increase healthcare costs across the board.

The Need for Reform

If Medicare Advantage is to fulfill its original promise of delivering better care at a lower cost, serious reforms are needed. This starts with curbing the industry’s ability to overbill Medicare by implementing stricter audits and penalties for upcoding and fraud. In addition, we need to limit the undue influence of lobbyists who prioritize corporate profits over the public good.

Medicare Advantage can still be essential in the healthcare system, but only if it operates with transparency and accountability. This will require elected officials to stop taking their marching orders from insurers and start prioritizing the needs of the American people.

The overbilling within Medicare Advantage is a glaring example of how corporate greed can distort a public program to help vulnerable populations.

Lobbyists’ success in protecting these fraudulent profits shows how deeply private money shapes healthcare policy. To protect Medicare and ensure that it serves seniors rather than private companies, policymakers must resist the temptations of lobbying dollars and act in the public interest.

Until then, the overbilling crisis will continue, draining taxpayer dollars and putting seniors at risk while enriching an industry that’s become expert at manipulating both the system and our political leaders.

Topics:

Richard Meyer

I’m Richard Meyer — a 25 year healthcare marketing strategist and writer focused on the intersection of direct-to-consumer marketing, healthcare economics, and human behavior.I started Work of DTC Marketing because too much of the conversation around pharma and healthcare marketing is either overly promotional, overly technical, or completely disconnected from how the system actually works.Here, I write about what DTC really does, how incentives drive behavior inside healthcare organizations, why patients are often treated like revenue streams instead of people, and why “best practices” are frequently just recycled assumptions.My background spans digital marketing, public relations, and healthcare strategy, and my approach is pragmatic, skeptical of hype, and grounded in data and lived experience. I’m less interested in what sounds good in a deck and more interested in what actually changes outcomes — for companies, doctors, and especially patients.

Leave a Reply

Send this to a friend